Portfolio comparison
Transkaryotic Therapies Inc vs Kite Pharma
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Transkaryotic Therapies Inc
Patents indexed
1
Year range
2003
Most recent
2003
biotechpharmaceutical
Top Patents1 enriched
US 6531124· 2003
How to Use Modified Cells to Produce Insulin-Regulating Proteins in the Body
Activity by Decade
2000s1
Company B
Kite Pharma
Patents indexed
1
Year range
2026
Most recent
2026
biotechpharmaceuticalgene_editingimmunotherapy
Top Patents1 enriched
US 12600775· 2026
Treating a Specific Lymphoma with Modified T Cells
Activity by Decade
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.